Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma

Abstract

ObjectivesHead and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide. Inconsistency in various histopathologic features for predicting nodal metastasis and overall prognosis and a better understanding of molecular mechanisms of tumourigenesis have shifted the focus to a search for more definitive predictive markers. To identify the role of two immunohistochemical (IHC) markers, E-cadherin and cyclin D1, as predictive markers of aggressiveness in HNSCC and to assess clonal expansion of tumour cells.Materials and MethodsA total of 66 cases of HNSCC with neck node dissection were studied. IHC was performed on primary tumour sections and lymph nodes showing metastatic deposits. Histopathological parameters such as tumour grade and TNM stage together with nodal status were compared according to expression of the two markers. Fischer's chi-square test was used to assess the correlation between the two markers and histopathological parameters.ResultsOut of 66 cases studied, 37 showed LN metastasis. Most of the patients were male, and the most common tumour site was buccal mucosa. We found a significant association between loss of E-cadherin and node metastasis (P<0.001) and higher TNM stage (P<0.001). Cyclin D1 overexpression was significantly associated with only nodal metastasis (P=0.007). No significant association with tumour grade was found for either marker. The subgroup of E-cadherin loss with cyclin D1 overexpression was associated with the maximum incidence of nodal metastasis and higher TNM stage, highlighting the importance of using a combination of these two markers. A significant association was noted between the expression of markers at the primary site and at nodal deposits, indicating clonal expansion.ConclusionA combination of the two markers E-cadherin and cyclin D1 can predict prognosis in HNSCC, although tumour heterogeneity may affect this association in some cases.

MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation

“…However, cyclin A is the only cyclin that exhibits a statistical difference between poorly differentiated and moderately differentiated cSCC with PNI (p = 0.0277). In contrast to other studies showing overexpression of cyclin D1 in SCC, we found no significant differences in cyclin D1 expression [37][38][39]. One possible explanation could be due to the fact that A431 and Pam 212 tumors potentially exhibit overexpression of different isoforms of cyclin D [40].…”

Elevated level of neuroserpin is an indication for the resistance to gambogic acid-induced apoptosis and oxidative stress in triple-negative breast cancer cells

“…E-cadherin expression is recognized to play a crucial role in the suppression of breast tumors such as head and neck squamous cell carcinoma aggressive cancers. The loss of E-cadherin may cause tumors to become more aggressive and increase their invasion ability and metastasis [ 31 ]. However, Nieman et al [ 32 ] showed that N-cadherin contributes motility of human BC cells regardless of their expression of E-cadherin.…”

The Effect of Ethanol Extract from Lingzhi Fungi (Ganoderma lucidum) Cianjur Isolate on E-Cadherin Expression KB CCL-17 Oral Cell Cancer

“…The cause of the lower E-cadherin expression is associated with several gene mutations. 11 Function changes of E-cadherin occur due to missense mutations in ovarian cancer. Ecadherin gene mutations are also found in diffuse gastric cancer with a percentage of 30%.…”